Clinical Trial Update: Empagliflozin in Post-Transplantation Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on empagliflozin for post-transplant diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttransplant Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Posttransplant Diabetes Mellitus | Phase 2 | Status: COMPLETED